|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Other operating income | |||||
| Selling, general and administrative, research and development expenses | |||||
| Other operating expenses | |||||
| Net impairment loss on financial and contract assets | |||||
| Operating profit | |||||
| Finance costs | |||||
| Finance income | |||||
| Share of loss of associates | |||||
| Gain on disposal of investment | |||||
| Exchange gain | |||||
| Other income | |||||
| Other expenses | |||||
| Profit before tax | |||||
| Income tax expense | |||||
| Profit/(loss) for the year | |||||
| Earnings per share | |||||
| Basic profit for the year attributable to equity holders of the parent (in USD per share) | |||||
| Diluted profit for the year attributable to equity holders of the parent (in USD per share) | |||||
| Attributable to: | |||||
| Equity holders of the parent | |||||
| Non-controlling interests | |||||
Loading...